The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 20, 2017

Filed:

Jun. 13, 2016
Applicant:

Quadriga Biosciences, Inc., Sunnyvale, CA (US);

Inventors:

Bernd Jandeleit, Menlo Park, CA (US);

Wolf-Nicolas Fischer, Sunnyvale, CA (US);

Kerry J. Koller, San Francisco, CA (US);

Assignee:

QUADRIGA BIOSCIENCES, INC., Sunnyvale, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07C 229/08 (2006.01); C07C 271/46 (2006.01); C07C 309/69 (2006.01); C07D 257/04 (2006.01); C07F 9/48 (2006.01); A61K 47/48 (2006.01); A61K 31/197 (2006.01); A61K 31/41 (2006.01); A61K 31/662 (2006.01); C07C 229/42 (2006.01); C07C 237/30 (2006.01); C07C 239/20 (2006.01); C07C 239/18 (2006.01); C07F 9/32 (2006.01);
U.S. Cl.
CPC ...
C07C 229/08 (2013.01); A61K 31/197 (2013.01); A61K 31/41 (2013.01); A61K 31/662 (2013.01); A61K 47/48038 (2013.01); C07C 229/42 (2013.01); C07C 237/30 (2013.01); C07C 239/18 (2013.01); C07C 239/20 (2013.01); C07C 271/46 (2013.01); C07C 309/69 (2013.01); C07D 257/04 (2013.01); C07F 9/3264 (2013.01); C07F 9/48 (2013.01); C07F 9/4816 (2013.01);
Abstract

β-Substituted γ-amino acids, β-substituted γ-amino acid derivatives, and β-substituted γ-amino acid analogs and (bio)isosteres and their use as chemotherapeutic agents are disclosed. The β-substituted γ-amino acid derivatives and β-substituted γ-amino acid analogs and (bio)isosteres are selective LAT1/4F2hc substrates, capable of passing through the blood-brain barrier, and exhibit rapid uptake and retention in tumors expressing the LAT1/4F2hc transporter. Methods of synthesizing the β-substituted γ-amino acid derivatives and β-substituted γ-amino acid analogs and (bio)isosteres and methods of using the compounds for treating tumors are also disclosed. The β-substituted γ-amino acid derivatives and β-substituted γ-amino acid analogs and (bio)isosteres exhibit an improved selectivity toward tumor cells expressing the LAT1/4F2hc transporter and accumulate in cancerous cells when administered to a subject in vivo. The β-substituted γ-amino acid derivatives and β-substituted γ-amino acid analogs and (bio)isosteres exhibit an increased efficacy on a variety of tumor types.


Find Patent Forward Citations

Loading…